2020-11-16T13:13:28-06:00 2019-12-31 111986323 MARCUM LLP 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 990 2019-01-01 520880522 FOUNDATION FOR CONTEMPORARY MENTAL HEALTH FOUN 2022967100 2112 F STREET NW NO 404 WASHINGTON DC 20037 DR HOWARD HOFFMAN PRESIDENT/CEO 2022967100 2020-11-16 1 AARON M FOX P01365820 2022274000 2020-11-16 144.121.95.190 2020-11-16 11:05:41 ES P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 E1E28523A2844DB397B81B80F2817153C3518583 2019 2021-01-29 14:40:06Z DR HOWARD HOFFMAN 2112 F STREET NW NO 404 WASHINGTON DC 20037 4008593 0 X N/A X 1967 DC TO PROVIDE SUBSTANCE ABUSE TREATMENT AND EDUCATION IN THE WASHINGTON METROPOLITAN AREA. 5 4 58 4 0 0 224561 199026 4030804 3806173 4209 3187 12231 207 4271805 4008593 0 0 0 0 3390679 3000863 0 0 0 1287645 1285311 4678324 4286174 -406519 -277581 1562111 1370322 364720 450512 1197391 919810 X FOUNDATION FOR CONTEMPORARY MENTAL HEALTH (THE FOUNDATION) IS ORGANIZED TO PROVIDE SUBSTANCE ABUSE TREATMENT AND EDUCATION IN THE WASHINGTON METROPOLITAN AREA WITH A SPECIAL INTEREST IN SERVING INDIGENT, UNINSURED AND UNDER-INSURED POPULATIONS. 0 1 3139680 3806173 PIDARC IS A PRIVATE OUTPATIENT MEDICATION ASSISTANT AND COUNSELING TREATMENT PROGRAM SERVICING AN AVERAGE MONTHLY CENSUS OF 645 PATIENTS IN THE WASHINGTON METROPOLITAN AREA, MOST OF WHOM ARE UNINSURED OR UNDERINSURED INDIVIDUALS. IN 2019, AN AVERAGE OF 345 PATIENTS WERE SEEN IN THE CLINIC DAILY. IN ADDITION TO PROVIDING TREATMENT FOR SUBSTANCE USE DISORDERS, PIDARC IS COMMITTED TO PROVIDING LINKAGES FOR PATIENTS TO ADDRESS THEIR MEDICAL AND PSYCHOSOCIAL NEEDS. TO THAT END, PIDARC REQUIRES PATIENTS TO HAVE A COMPREHENSIVE PHYSICAL EXAMINATION FROM A PRIMARY CARE PROVIDER AND HAS A MEMORANDUM OF UNDERSTANDING WITH A PRACTICE IN THE SAME BUILDING TO PROVIDE PHYSICALS FOR THOSE PATIENTS WHO HAVE NOT YET IDENTIFIED A PRIMARY CARE DOCTOR. IN 2019, 935 PATIENTS RECEIVED AN ANNUAL PHYSICAL EXAM WHICH WAS REVIEWED WITH THEM BY A PIDARC NURSE AND FOLLOW UP APPOINTMENTS FOR SPECIALTY MEDICAL SERVICES WERE MADE, WHEN INDICATED. IN ADDITION, 864 REFERRALS WERE MADE AND TRACKED FOR CASE MANAGEMENTS SERVICES TO ADDRESS MENTAL HEALTH, HOUSING, EMPLOYMENT, FINANCIAL, AND TRANSPORTATION NEEDS. 199711 DISTRICT OPIOID TARGETED STRATEGIES - IN 2019, THE FOUNDATION RECEIVED A GRANT FROM THE DEPARTMENT OF BEHAVIORAL HEALTH FOR THE PURPOSE OF IDENTIFYING PATIENTS TO RECEIVE COMPREHENSIVE PHYSICALS, EKGS AND TB TESTS ANNUALLY AND LINKING THEM WITH PRIMARY CARE SERVICES. THE GRANT PAID FOR SALARIES, BENEFITS AND ASSOCIATED OPERATIONAL AND ADMINISTRATIVE COSTS FOR TWO INDIVIDUALS TO WORK WITH THE PATIENTS ON A CASE MANAGEMENT BASIS TO SCHEDULE AND FOLLOW UP ON THEIR PARTICIPATION WHILE ALSO COLLECTING REQUIRED DATA. 3339391 1 1 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 9 0 1 58 1 0 0 0 0 0 0 0 0 0 0 0 0 X 5 4 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 0 0 DC X AUDREY CANNAMELA 2022967100 2112 F STREET NW NO 404 WASHINGTON DC 20037 DR HOWARD HOFFMAN PRESIDENT/CEO 40.00 X X 224355 0 29567 AUDREY CANNAMELA EXECUTIVE DIRECTOR 40.00 X 170758 0 17921 BRIAN CRISSMAN ASSISTANT DIRECTOR 40.00 X 118140 0 6690 JOANNE HOUSTON (OPEN) 40.00 X 115300 0 0 JOSHUA MUSS SECRETARY 1.00 X X 0 0 0 FRANCINE LEVINSON TREASURER 1.00 X X 0 0 0 CECELIA SCORAH DIRECTOR 1.00 X 0 0 0 BRAD SPENCER DIRECTOR 1.00 X 0 0 0 628553 0 54178 4 0 1 0 MARCUM LLP 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 ACCOUNTING/HR/TECH. SERVICES 214693 1 199026 199026 PIDARC TREATMENT 900099 3806173 3806173 3806173 3187 3187 MISCELLANEOUS INCOME 900099 207 207 207 4008593 3806173 0 3394 442601 177746 264855 2094198 1949356 144842 39588 38003 1585 216903 182649 34254 207573 179789 27784 11790 11790 16171 16171 291874 50621 241253 10545 4952 5593 150579 127817 22762 501497 384332 117165 732 732 2149 1974 175 27490 23535 3955 48245 570 47675 TREATMENT 148775 148775 BAD DEBT EXPENSE 54996 54996 PROF. DEVELOPMENT 10856 10856 MEMBERSHIP DUES 9594 2670 6924 18 18 4286174 3339391 946783 0 231106 135293 286184 286012 484443 412074 62638 65667 329649 258832 97453 70817 377072 377244 23215 23215 1562111 1370322 248143 313419 50000 116577 87093 364720 450512 X 1197391 919810 1197391 919810 1562111 1370322 -277581 0 X 0 0 0 X 200 640 39424 224561 199062 463887 3939781 4195562 4505556 4030804 3806173 20477876 3939981 4196202 4544980 4255365 4005235 20941763 0 0 0 20941763 35089 36257 35466 16440 3187 126439 35089 36257 35466 16440 3187 126439 115 207 322 3975070 4232459 4580561 4271805 4008629 21068524 0.99400 0.99250 0.00600 0.00750 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2015 AMOUNT: $ 0. 2016 AMOUNT: $ 0. 2017 AMOUNT: $ 115. 2018 AMOUNT: $ 0. 2019 AMOUNT: $ 207. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 102141 87275 14866 86715 54929 31786 140793 116628 24165 70817 CERTIFICATES OF DEPOSIT 377244 C 377244 DEFERRED RENT 50034 CAPITAL LEASE OBLIGATION 37059 87093 X X 0 0 0 0 0 0 0 0 0 DR HOWARD HOFFMAN PRESIDENT/CEO 224355 0 0 0 0 0 9708 0 19859 0 253922 0 0 0 AUDREY CANNAMELA EXECUTIVE DIRECTOR 170758 0 0 0 0 0 7128 0 10793 0 188679 0 0 0 DR HOWARD HOFFMAN PRESIDENT/CEO 120914 THE FOUNDATION PAYS RENT TO BAINBRIDGE ASSOCIATION WHERE DR. HOWARD HOFFMAN, PRESIDENT/CEO OF THE FOUNDATION, IS AN OFFICER OF BAINBRIDGE ASSOCIATION. THE FOUNDATION ALSO LEASES OFFICE SPACES AND IS ASSESSED REAL ESTATE TAXES AND CONDO FEES FOR THE OFFICE SPACE. RENT IS ASSESSED BELOW MARKET VALUE. 0 FORM 990, PART III, LINE 3 THE FOUNDATION CEASED ITS NEXT STEP PROGRAM IN 2019. FORM 990, PART VI, SECTION B, LINE 11B THE PRESIDENT/CEO REVIEWS THE DRAFT FEDERAL FORM 990 WITH THE EXECUTIVE COMMITTEE. THE FEDERAL FORM 990 IS THEN SIGNED AND FILED WITH THE INTERNAL REVENUE SERVICE. AFTER FINALIZATION, THE FINALIZED FORM 990 IS DISCUSSED AT THE NEXT MEETING OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C THE OFFICERS AND DIRECTORS ARE REQUIRED TO SIGN A DISCLOSURE FORM RELATED TO CONFLICTS OF INTEREST POLICY ON AN ANNUAL BASIS. THE DISCLOSURES ARE REVIEWED AND ANY POTENTIAL CONFLICTS ARE ADDRESSED ACCORDING TO THE FOUNDATION'S POLICY. 1. DUTY TO DISCLOSE. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS EITHER TO THE BOARD OF DIRECTORS OR TO MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. 2. DETERMINING WHETHER A CONFLICT OF INTEREST EXISTS AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE SHALL LEAVE THE BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON BY THE MEMBERS PRESENT. 3. PROCEDURES FOR ADDRESSING THE CONFLICT OF INTEREST A. AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE BOARD OF DIRECTOR'S MEETING, BUT AFTER THE PRESENTATION, HE/SHE SHALL LEAVE THE MEETING DURING THE DISCUSSION OF AND THE VOTE ON THE TRANSACTION OR ARRANGEMENT INVOLVING THE POSSIBLE CONFLICT OF INTEREST. B. THE PRESIDENT SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. IF THE POTENTIAL CONFLICT OF INTEREST INVOLVES THE PRESIDENT, THE TREASURER SHALL APPOINT AN INVESTIGATOR. ANY FINDINGS MADE BY THE APPOINTED INVESTIGATOR/COMMITTEE WILL BE PRESENTED TO THE BOARD OF DIRECTORS. C. AFTER EXERCISING DUE DILIGENCE, THE BOARD OF DIRECTORS SHALL DETERMINE WHETHER THE FOUNDATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. D. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE, THE BOARD OF DIRECTORS SHALL DETERMINE, BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS, WHETHER THE TRANSACTION OR ARRANGEMENT IS IN THE FOUNDATION'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION IT SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT. 4. VIOLATIONS OF THE CONFLICTS OF INTEREST POLICY A. IF THE BOARD OF DIRECTORS HAS REASONABLE CAUSE TO BELIEVE ANY PERSON HAS FAILED TO DISCLOSE ACTUAL OR POSSIBLE CONFLICTS OF INTEREST, IT SHALL INFORM THAT PERSON OF THE BASIS FOR SUCH BELIEF AND AFFORD THAT PERSON AN OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. B. IF, AFTER HEARING ANY RESPONSE AND AFTER MAKING FURTHER INVESTIGATION AS WARRANTED BY THE CIRCUMSTANCES, THE BOARD OF DIRECTORS DETERMINE THAT THE PERSON HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT SHALL TAKE APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION. FORM 990, PART VI, SECTION B, LINE 15A THE FOUNDATION USES A COMPENSATION COMMITTEE, A WRITTEN EMPLOYMENT CONTRACT, REQUIRES APPROVAL BY THE BOARD OF DIRECTORS, AND HAS CONTEMPORANEOUS WRITTEN SUBSTANTIATION OF THE DECISION-MAKING PROCESS FOR DETERMINING CEO COMPENSATION. FOR THE EXECUTIVE DIRECTOR, THE PRESIDENT/CEO PRESENTS A SUMMARY OF THE EXECUTIVE DIRECTOR'S ACTIVITIES AND ACCOMPLISHMENTS TO THE BOARD OF DIRECTOR'S COMPENSATION COMMITTEE AND WILL MAKE A RECOMMENDATION FOR COMPENSATION FOR BOARD APPROVAL. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.